Literature DB >> 12791924

Plasma versus serum for detection of herpes simplex virus type 2-specific immunoglobulin G antibodies with a glycoprotein G2-based enzyme immunoassay.

Thomas L Cherpes1, Leslie A Meyn, Sharon L Hillier.   

Abstract

To evaluate the consonance between plasma and serum for the detection of herpes simplex virus type 2-specific immunoglobulin G antibodies, we compared results from concurrently obtained plasma and sera in 710 sexually active women by using a glycoprotein G2-based enzyme-linked immunosorbent assay (Focus Technologies, Cypress, Calif.) and found 98.9% agreement between the two specimen types. Plasma appears to be an acceptable matrix for use with this assay.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12791924      PMCID： PMC156559          DOI： 10.1128/JCM.41.6.2758-2759.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  7 in total

1.  Longitudinal reliability of focus glycoprotein G-based type-specific enzyme immunoassays for detection of herpes simplex virus types 1 and 2 in women.

Authors:  Thomas L Cherpes; Rhoda L Ashley; Leslie A Meyn; Sharon L Hillier
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

2.  Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis.

Authors:  Anna Wald; Katherine Link
Journal:  J Infect Dis       Date:  2001-12-14       Impact factor: 5.226

3.  Use of a glycoprotein G-based type-specific assay to detect antibodies to herpes simplex virus type 2 among persons attending sexually transmitted disease clinics.

Authors:  W L Whittington; C L Celum; A Cent; R L Ashley
Journal:  Sex Transm Dis       Date:  2001-02       Impact factor: 2.830

4.  Comparative performance of herpes simplex virus type 2-specific serologic assays from Meridian Diagnostics and MRL diagnostics.

Authors:  J A Ribes; M Hayes; A Smith; J L Winters; D J Baker
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

5.  Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease.

Authors:  Harold C Wiesenfeld; Sharon L Hillier; Marijane A Krohn; Antonio J Amortegui; R Phillips Heine; Daniel V Landers; Richard L Sweet
Journal:  Obstet Gynecol       Date:  2002-09       Impact factor: 7.661

6.  Identification and preliminary mapping with monoclonal antibodies of a herpes simplex virus 2 glycoprotein lacking a known type 1 counterpart.

Authors:  B Roizman; B Norrild; C Chan; L Pereira
Journal:  Virology       Date:  1984-02       Impact factor: 3.616

7.  Comparative stabilities of quantitative human immunodeficiency virus RNA in plasma from samples collected in VACUTAINER CPT, VACUTAINER PPT, and standard VACUTAINER tubes.

Authors:  M Holodniy; L Mole; B Yen-Lieberman; D Margolis; C Starkey; R Carroll; T Spahlinger; J Todd; J B Jackson
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948
  7 in total
  9 in total

1.  Correlation between serum and plasma antibody titers to mycobacterial antigens.

Authors:  Michael Siev; Xian Yu; Rafael Prados-Rosales; Frank T Martiniuk; Arturo Casadevall; Jacqueline M Achkar
Journal:  Clin Vaccine Immunol       Date:  2010-11-03

2.  Evaluation of Herpes Simplex Virus Type 2 Serological Tests for Use With Dried Blood Spots in Kenya.

Authors:  Marcia M Hobbs; Sophie W Mwanyumba; Winnie K Luseno; Shane Hartman; Carolyn T Halpern; Denise D Hallfors; Hyunsan Cho
Journal:  Sex Transm Dis       Date:  2017-02       Impact factor: 2.830

3.  Serologic Evidence of Gut-driven Systemic Inflammation in Juvenile Idiopathic Arthritis.

Authors:  Lampros Fotis; Nurmohammad Shaikh; Kevin W Baszis; Charles M Samson; Raffi Lev-Tzion; Anthony R French; Phillip I Tarr
Journal:  J Rheumatol       Date:  2017-09-15       Impact factor: 4.666

4.  Factors associated with herpes simplex virus type 2 incidence in a cohort of human immunodeficiency virus type 1-seronegative Kenyan men and women reporting high-risk sexual behavior.

Authors:  Haile Selassie Okuku; Eduard J Sanders; Joyce Nyiro; Caroline Ngetsa; Eric Ohuma; R Scott McClelland; Matthew A Price; Susan M Graham
Journal:  Sex Transm Dis       Date:  2011-09       Impact factor: 2.830

5.  The diagnosis of genital herpes - beyond culture: An evidence-based guide for the utilization of polymerase chain reaction and herpes simplex virus type-specific serology.

Authors:  S Ratnam; A Severini; G Zahariadis; M Petric; B Romanowski
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-07       Impact factor: 2.471

6.  A prospective study of risk factors for herpes simplex virus type 2 acquisition among high-risk HIV-1 seronegative women in Kenya.

Authors:  V Chohan; J M Baeten; S Benki; S M Graham; L Lavreys; K Mandaliya; J O Ndinya-Achola; W Jaoko; J Overbaugh; R S McClelland
Journal:  Sex Transm Infect       Date:  2009-05-19       Impact factor: 3.519

7.  Genetic Analysis of a Commercial Egg Laying Line Challenged With Newcastle Disease Virus.

Authors:  Kaylee Rowland; Anna Wolc; Rodrigo A Gallardo; Terra Kelly; Huaijun Zhou; Jack C M Dekkers; Susan J Lamont
Journal:  Front Genet       Date:  2018-08-20       Impact factor: 4.599

8.  Chagas Disease Serological Test Performance in U.S. Blood Donor Specimens.

Authors:  Jeffrey D Whitman; Christina A Bulman; Emma L Gunderson; Amanda M Irish; Rebecca L Townsend; Susan L Stramer; Judy A Sakanari; Caryn Bern
Journal:  J Clin Microbiol       Date:  2019-11-22       Impact factor: 5.948

9.  Serosurveillance and Molecular Investigation of Wild Deer in Australia Reveals Seroprevalence of Pestivirus Infection.

Authors:  Jose L Huaman; Carlo Pacioni; David M Forsyth; Anthony Pople; Jordan O Hampton; Teresa G Carvalho; Karla J Helbig
Journal:  Viruses       Date:  2020-07-13       Impact factor: 5.048
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.